Tokyo Tape
Sign in
← Kanamic Network

Quarterly report · Q2

3939.TEDINET S100TDG1
Period2023-10-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥2.4bn2023-10-01 → 2024-03-31Cons.Net sales
Revenue¥3.7bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥1.7bn2022-10-01 → 2023-03-31Cons.Net sales
Operating income¥669m2023-10-01 → 2024-03-31Cons.Operating income
Operating income¥559m2022-10-01 → 2023-03-31Cons.Operating income
Ordinary income¥675m2023-10-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥1.1bn2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥565m2022-10-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥684m2023-10-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥588m2022-10-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥458m2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥763m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥406m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥458m2023-10-01 → 2024-03-31Cons.Profit loss
Net income¥406m2022-10-01 → 2023-03-31Cons.Profit loss
Total assets¥5.6bnat 2024-03-31Cons.Assets
Total assets¥5.7bnat 2023-09-30Cons.Assets
Total assets¥6.5bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥2.2bnat 2024-03-31Cons.Liabilities
Total liabilities¥2.5bnat 2023-09-30Cons.Liabilities
Net assets / equity¥3.4bnat 2024-03-31Cons.Net assets
Net assets / equity¥3.2bnat 2023-09-30Cons.Net assets
Net assets / equity¥2.8bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥2.7bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥2.9bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥2.7bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥4.2bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥4.6bnat 2022-09-30dCons.Cash and cash equivalents
Operating cash flow¥438m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.4bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥339m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥194m2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥842m2022-10-01 → 2023-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥242m2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥434m2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.3bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥405m2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥9.652023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.272024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥16.082022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥8.552022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.062023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥15.582022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥8.092022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio60.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.2%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio43.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥5m
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥5m
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥21m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥613m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥613m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥15m
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥1.6bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥1.6bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥1m
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥641m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥285m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥281m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥4m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥34m
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2024-03-31¥2.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2024-03-31¥2.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-10-01 → 2024-03-31¥5m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-10-01 → 2024-03-31¥690m
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥52,000
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥52,000
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥3m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue2022-10-01 → 2023-03-31¥384m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue external2022-10-01 → 2023-03-31¥384m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentsegment profit2022-10-01 → 2023-03-31¥10m
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue2022-10-01 → 2023-03-31¥1.4bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue external2022-10-01 → 2023-03-31¥1.4bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥52,000
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentsegment profit2022-10-01 → 2023-03-31¥553m
Total Of Reportable Segments And Otherssegment totalrevenue2022-10-01 → 2023-03-31¥1.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-10-01 → 2023-03-31¥1.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-10-01 → 2023-03-31¥52,000
Total Of Reportable Segments And Otherssegment totalsegment profit2022-10-01 → 2023-03-31¥563m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 539
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember13680000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.2882
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember6689600
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1409
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember3348000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0705
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember2354000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0496
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember1405600
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0296
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember905600
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0190
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember850400
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0179
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember775400
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0163
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember727600
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0153
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember549100
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0115
Number of shares heldCurrentQuarterInstant31285300
Shareholding ratioCurrentQuarterInstant0.6592
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember673700
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember47439900
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember474399
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember18400
Number of shares issued shares voting rightsCurrentQuarterInstant48132000
Number of voting rights issued shares voting rightsCurrentQuarterInstant474399
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member673700
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member673700
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.014
Number of shares held in own name treasury shares etcCurrentQuarterInstant673700
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant673700
Shareholding ratio treasury shares etcCurrentQuarterInstant0.014
Cash and depositsPrior1YearInstant2872526000JPY
Cash and depositsCurrentQuarterInstant2685522000JPY
Accounts receivable tradePrior1YearInstant183489000JPY
Accounts receivable tradeCurrentQuarterInstant313879000JPY
MerchandisePrior1YearInstant7260000JPY
MerchandiseCurrentQuarterInstant6260000JPY
Work in processPrior1YearInstant2163000JPY
Work in processCurrentQuarterInstant442000JPY
SuppliesPrior1YearInstant400000JPY
SuppliesCurrentQuarterInstant1712000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass